Mercury Rhinomanometer
510(k) K902120
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK902120 | Date6 Aug 1990 | StatusActive |
Recalls
No FDA recalls found in the data synced 6 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- BXQ
- Device Class
- Class II
- Regulation
- 21 CFR Part 868.1800
- Advisory Committee
- Anesthesiology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 24 Sep 2026
The Mercury Rhinomanometer is a medical device designed for the measurement of nasal decongestion. It functions as a rhinoanemometer to assess nasal airway resistance and airflow characteristics.
This device is identified by FDA 510(k) clearance number K902120. It is classified under regulation number 868.1800 and is associated with the product code BXQ.
Other devices from Life-Tech Intl., Inc.
Questions
AI-generated answers, 24 Sep 2026
What is the primary clinical purpose of the Mercury Rhinomanometer?
The Mercury Rhinomanometer is designed to assess nasal airway resistance and airflow characteristics. It functions as a rhinoanemometer to provide objective measurements of nasal decongestion for clinical evaluation.
What is the regulatory status of this device?
The Mercury Rhinomanometer has received FDA 510(k) clearance under the number K902120. It is classified under regulation number 868.1800 and is categorized under product code BXQ within the Anesthesiology medical specialty.
Who is the manufacturer of the Mercury Rhinomanometer?
The device is manufactured by Life-Tech Intl., Inc., based in Houston, Texas. The company submitted the device for regulatory review, which resulted in a determination of substantial equivalence.